We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
MHRA advises the Cell Therapy Catapult on emerging clinical grade induced pluripotent stem cells bank regulation.
The expert working group of the UK’s Commission on Human Medicines (CHM) has reached their conclusion on the use of alteplase in the treatment of ischaemic stroke.
Steel cannula infusion sets manufactured by Unomedical should be checked due to small risk of needle breaking.
MHRA can place UK at the forefront of a global drive to improve public health according to Triennial Review.
MHRA is seeking your views on draft guidance on the re-manufacture of single use devices.
The British Pharmacopoeia Commission is seeking to appoint 8 new members (6 professional members and 2 lay members).
6 November 2015: registration for the good pharmacovigilance practice symposium (GPvP) in London is now open.
UK BioIndustry Association (BIA) and the Medicines and Healthcare products Regulatory Agency (MHRA) report following their fifth joint annual conference.
A Yellow Card smartphone app has been launched today for people to report problems with medicines.
A major healthcare company and a sister company have been sentenced for supplying hospitals with defective pre-filled syringes.
The 2015/16 business plan for the Medicines and Healthcare products Regulatory Agency has been published today (30 June 2015).
A new case study is out showing how FUJIFILM Diosynth Biotechnologies (Fujifilm) engaged MHRA early to future-proof mammalian cell culture manufacturing facility.
51-year-old woman sentenced to 27 months imprisonment for her involvement in the supply of abortion pills with intent to unlawfully procure miscarriages.
How we helped FUJIFILM Diosynth Biotechnologies (Fujifilm) future proof mammalian cell culture manufacturing facility.
MHRA has today published its first blog.
MHRA announced £15.8 million worth of counterfeit and unlicensed medicines and devices have been seized in the UK.
From 1 July anybody in the UK selling medicines online to the general public needs to be registered with the MHRA and to be on the MHRA’s list of UK registered online retail sellers.
A 29 year old man was sentenced to prison for selling counterfeit and prescription-only medicines.
MHRA is asking healthcare professionals for feedback on how it communicates medicines safety issues.
From 1 July 2015, MHRA will fully adopt use of the common repository for centralised procedures.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).